Andy has taken the time to tell us how living with Diabetes Type 1 has changed his life.
It’s an exciting time to be in the Biomarkers industry, with advances far surpassing anything we could have dreamed of in the 80’s. Our very own Doc.. Simon Packer attended the 11th Biomarkers Congress in Manchester where leading experts in the industry and academia come together to present advances in biomarker discovery.
In this newsflash find out about our Disease State Plasma range and be one of the first to learn about our exciting new product launch of Clinical Specimen Panels coming soon to the BBI Solutions product portfolio.
Find out about our newly developed CEA antibody pairings in this month’s Antibodies Newsflash as well as new data on HIV p24 and Vancomycin A Monoclonals.
BBI Solutions demonstrates its commitment to biosensor market with the launch of a new grade of FAD-GDH
BBI Solutions (BBI) has announced the launch of a next generation FAD-dependent Glucose Dehydrogenase (FAD-GDH) for blood glucose monitoring.